|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0100 CAD | 0.00% |
|
0.00% | -83.33% |
| Market Cap | 11.94L 8L 7L 7L 6L 8.16Cr 12.12L 82.23L 32.13L 4.01Cr 31.82L 31.14L 14Cr | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 5L 3L 3L 3L 3L 3.22Cr 5L 32.4L 12.66L 1.58Cr 12.54L 12.27L 5.47Cr | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 month | -33.33% | ||
| 3 months | -33.33% | ||
| 6 months | -71.43% | ||
| Current year | -83.33% |
| 1 week | 0.01 |  | 0.01 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.25 |
| 3 years | 0 | | 0.25 |
| 5 years | 0 | | 0.8 |
| 10 years | 0 | | 1.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 01/10/2019 |
José Roldan
DFI | Director of Finance/CFO | - | 09/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 01/10/2019 |
Daniel Augereau
BRD | Director/Board Member | 82 | 01/10/2019 |
Eric Klein
BRD | Director/Board Member | 66 | 01/10/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/06/25 | Sell | Chief Executive Officer | 46,67,000 | 3.9091% | ||
| 21/03/25 | Buy | Chief Executive Officer | 1,00,000 | 0.0838% | ||
| 21/03/25 | Buy | Chief Executive Officer | 2,00,000 | 0.1675% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -33.33% | -83.33% | 8L | |
| +0.86% | +1.43% | +48.50% | +160.39% | 1,06700Cr | |
| +1.59% | +4.09% | +55.34% | +53.96% | 63TCr | |
| +0.95% | +1.91% | +35.91% | +81.14% | 46TCr | |
| +1.60% | +6.25% | +33.95% | +29.84% | 35TCr | |
| -0.60% | +1.52% | +35.68% | +39.76% | 30TCr | |
| -0.14% | +0.60% | +16.17% | +17.53% | 26TCr | |
| +0.09% | -2.82% | -28.29% | -41.71% | 22TCr | |
| +1.22% | +2.66% | +21.87% | +59.73% | 20TCr | |
| -1.18% | -3.70% | +14.23% | +66.51% | 16TCr | |
| Average | +0.33% | +1.19% | +20.00% | +38.38% | 36.43TCr | |
| Weighted average by Cap. | +0.55% | +1.95% | +35.81% | +77.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 43.42L 30.83L 27.08L 25.18L 23.11L 30Cr 44.09L 2.99Cr 1.17Cr 15Cr 1.16Cr 1.13Cr 50Cr | 33.61L 23.86L 20.96L 19.49L 17.89L 23Cr 34.12L 2.31Cr 90.43L 11Cr 89.58L 87.65L 39Cr |
| Net income | -1.65Cr -1.17Cr -1.03Cr -95.71L -87.83L -112.84Cr -1.68Cr -11Cr -4.44Cr -55Cr -4.4Cr -4.3Cr -191.82Cr | -89.1L -63.27L -55.57L -51.68L -47.42L -61Cr -90.47L -6.14Cr -2.4Cr -30Cr -2.38Cr -2.32Cr -103.57Cr |
| Net Debt | -6L -4L -4L -4L -3L -4.28Cr -6L -43.1L -16.84L -2.1Cr -16.68L -16.32L -7.27Cr | -7L -5L -5L -4L -4L -4.95Cr -7L -49.83L -19.47L -2.43Cr -19.29L -18.87L -8.41Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | CA$0.0100 | 0.00% | 1,000 |
| 17/26/17 | CA$0.0100 | +100.00% | 1,100 |
- Stock Market
- Stocks
- RAMM Stock
Select your edition
All financial news and data tailored to specific country editions
